洁特生物跌2.01%，成交额2626.25万元，主力资金净流出111.38万元

Company Overview - Jiet Bio is located in Guangzhou Economic and Technological Development Zone, established on April 11, 2001, and listed on January 22, 2020 [1] - The company specializes in cell culture and related products, classified under the pharmaceutical and biological industry, specifically in medical devices and consumables [1] Stock Performance - As of August 22, Jiet Bio's stock price decreased by 2.01%, trading at 19.46 CNY per share, with a total market capitalization of 2.731 billion CNY [1] - Year-to-date, the stock has increased by 52.53%, but has seen a decline of 3.42% over the last five trading days [1] - The stock has experienced a 0.83% increase over the last 20 days and a 23.73% increase over the last 60 days [1] Financial Performance - For the period from January to March 2025, Jiet Bio reported a revenue of 124 million CNY, reflecting a year-on-year growth of 26% [1] - The company has distributed a total of 152 million CNY in dividends since its A-share listing, with 30.06 million CNY distributed over the last three years [1] Shareholder Information - As of March 31, 2025, Jiet Bio had 7,864 shareholders, an increase of 3.79% from the previous period, with an average of 17,837 circulating shares per shareholder, a decrease of 3.65% [1] - Among the top ten circulating shareholders, the Jia Shi Leading Advantage Mixed A fund holds 1.6695 million shares, unchanged from the previous period [2]